col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


89 Results       Page 1

 [1] 
Elsevier: Antiviral Research
  original article Date Title Authors   All Authors
1 [GO] 2022―Sep―23 Repurposing of HIV/HCV protease inhibitors against SARS-CoV-2 3CLpro Ling Ma, Quanjie Li, Yongli Xie, Dongrong Yi, Saisai Guo, Fei Guo, et al. (+3)
2 [GO] 2022―Aug―28 Brequinar and dipyridamole in combination exhibits synergistic antiviral activity against SARS-CoV-2 in vitro: Rationale for a host-acting antiviral treatment strategy for COVID-19 James F. Demarest, Maryline Kienle, RuthMabel Boytz, Mary Ayres, Eun Jung Kim, Justin J. Patten, et al. (+7)
3 [GO] 2022―Aug―17 Punicalagin as an allosteric NSP13 helicase inhibitor potently suppresses SARS-CoV-2 replication in vitro Lian Lu, Yun Peng, Huiqiao Yao, Yanqun Wang, Jinyu Li, Yang Yang, Zhonghui Lin
4 [GO] 2022―Jul―31 Rational design of AAVrh10-vectored ACE2 functional domain to broadly block the cell entry of SARS-CoV-2 variants Minchao Li, Jiaoshan Chen, Yajie Liu, Jin Zhao, Yanjun Li, Yunqi Hu, et al. (+5)
5 [GO] 2022―Jul―11 Allosteric inhibitors of the main protease of SARS-CoV-2 Subodh Kumar Samrat, Jimin Xu, Xuping Xie, Eleonora Gianti, Haiying Chen, Jing Zou, et al. (+8)
6 [GO] 2022―Jul―04 Different efficacies of neutralizing antibodies and antiviral drugs on SARS-CoV-2 Omicron subvariants, BA.1 and BA.2 Hirofumi Ohashi, Takayuki Hishiki, Daisuke Akazawa, Kwang Su Kim, Joohyeon Woo, Kaho Shionoya, et al. (+17)
7 [GO] 2022―Jul―04 Hydroxypropyl-beta-cyclodextrin (HP-BCD) inhibits SARS-CoV-2 replication and virus-induced inflammatory cytokines Bruno Braz Bezerra, Gustavo Peixoto Duarte da Silva, Sharton Vinicius Antunes Coelho, Isadora Alonso Correa, Marcos Romario Matos de Souza, Keylla Vitória Gomes Macedo, et al. (+6)
8 [GO] 2022―Jun―29 Inhibition of a broad range of SARS-CoV-2 variants by antiviral phytochemicals in hACE2 mice Eun-Ha Kim, Ba Wool Lee, Byeol Ryu, Hyo Moon Cho, Se-Mi Kim, Seung-Gyu Jang, et al. (+6)
9 [GO] 2022―Jun―27 A circular mRNA vaccine prototype producing VFLIP-X spike confers a broad neutralization of SARS-CoV-2 variants by mouse sera Chotiwat Seephetdee, Kanit Bhukhai, Nattawut Buasri, Puttipatch Leelukkanaveera, Pat Lerdwattanasombat, Suwimon Manopwisedjaroen, et al. (+7)
10 [GO] 2022―Jun―21 Numb-associated kinases are required for SARS-CoV-2 infection and are cellular targets for antiviral strategies Marwah Karim, Sirle Saul, Luca Ghita, Malaya Kumar Sahoo, Chengjin Ye, Nishank Bhalla, et al. (+12)
11 [GO] 2022―Jun―19 Bergamottin, a bioactive component of bergamot, inhibits SARS-CoV-2 infection in golden Syrian hamsters Minmin Zhou, Yang Liu, Junyuan Cao, Siqi Dong, Yuxia Hou, Yan Yu, et al. (+7)
12 [GO] 2022―Jun―16 Identification of potent inhibitors of arenavirus and SARS-CoV-2 exoribonucleases by fluorescence polarization assay Sergio Hernández, Mikael Feracci, Carolina Trajano De Jesus, Priscila El Kazzi, Rafik Kaci, Laura Garlatti, et al. (+10)
13 [GO] 2022―Jun―10 Conserved coronavirus proteins as targets of broad-spectrum antivirals Cleber C. Melo-Filho, Tesia Bobrowski, Holli-Joi Martin, Zoe Sessions, Konstantin Popov, Nathaniel J. Moorman, et al. (+3)
14 [GO] 2022―Jun―07 Discovery of novel SARS-CoV-2 inhibitors targeting the main protease Mpro by virtual screenings and hit optimization Beatrice Mercorelli, Jenny Desantis, Marta Celegato, Alessandro Bazzacco, Lydia Siragusa, Paolo Benedetti, et al. (+5)
15 [GO] 2022―May―28 A novel high-throughput single B-cell cloning platform for isolation and characterization of high-affinity and potent SARS-CoV-2 neutralizing antibodies Paritosh Prashar, Sonali Swain, Nisha Adhikari, Punit Aryan, Anupama Singh, Mohit Kwatra, Prabhakar B
16 [GO] 2022―May―21 Animal models for studying coronavirus infections and developing antiviral agents and vaccines Qisheng Lin, Chunni Lu, Yuqi Hong, Runfeng Li, Jinding Chen, Weisan Chen, Jianxin Chen
17 [GO] 2022―May―19 Immunodetection assays for the quantification of seasonal common cold coronaviruses OC43, NL63, or 229E infection confirm nirmatrelvir as broad coronavirus inhibitor Tatjana Weil, Jan Lawrenz, Alina Seidel, Jan Münch, Janis A. Müller
18 [GO] 2022―May―19 Discovery of compounds that inhibit SARS-CoV-2 Mac1-ADP-ribose binding by high-throughput screening Anu Roy, Yousef M. Alhammad, Peter McDonald, David K. Johnson, Junlin Zhuo, Sarah Wazir, et al. (+4)
19 [GO] 2022―May―18 SARS-CoV-2 Permissive glioblastoma cell line for high throughput antiviral screening Emiel Vanhulle, Joren Stroobants, Becky Provinciael, Anita Camps, Sam Noppen, Piet Maes, Kurt Vermeire
20 [GO] 2022―May―07 Development of a cost-effective ovine antibody-based therapy against SARS-CoV-2 infection and contribution of antibodies specific to the spike subunit proteins Stephen Findlay-Wilson, Linda Easterbrook, Sandra Smith, Neville Pope, Gareth Humphries, Holger Schuhmann, et al. (+15)
21 [GO] 2022―May―05 Intravenous delivery of GS-441524 is efficacious in the African green monkey model of SARS-CoV-2 infection Jared Pitts, Darius Babusis, Meghan S. Vermillion, Raju Subramanian, Kim Barrett, Diane Lye, et al. (+14)
22 [GO] 2022―Apr―04 HIV protease inhibitors Nelfinavir and Lopinavir/Ritonavir markedly improve lung pathology in SARS-CoV-2-infected Syrian hamsters despite lack of an antiviral effect Caroline S. Foo, Rana Abdelnabi, Suzanne J.F. Kaptein, Xin Zhang, Sebastiaan ter Horst, Raf Mols, et al. (+20)
23 [GO] 2022―Mar―24 Isolation of human monoclonal antibodies with neutralizing activity to a broad spectrum of SARS-CoV-2 viruses including the Omicron variants Mikako Ueno, Naoko Iwata-Yoshikawa, Akihito Matsunaga, Tadashi Okamura, Sho Saito, Shinobu Ashida, et al. (+17)
24 [GO] 2022―Mar―13 Neutralization or enhancement of SARS-CoV-2 infection by a monoclonal antibody targeting a specific epitope in the spike receptor-binding domain Guan-Chun Lai, Tai-Ling Chao, Shiau-Yu Lin, Han-Chieh Kao, Ya-Min Tsai, De-Chao Lu, et al. (+3)
25 [GO] 2022―Mar―11 Novel antiviral activity of PAD inhibitors against human beta-coronaviruses HCoV-OC43 and SARS-CoV-2 Selina Pasquero, Francesca Gugliesi, Gloria Griffante, Valentina Dell’Oste, Matteo Biolatti, Camilla Albano, et al. (+6)
26 [GO] 2022―Mar―09 Label-free duplex SAMDI-MS screen reveals novel SARS-CoV-2 3CLpro inhibitors. M.D. Scholle, P. O'Kane, S. Dib, Z.A. Gurard-Levin
27 [GO] 2022―Mar―09 A highly sensitive cell-based luciferase assay for high-throughput automated screening of SARS-CoV-2 nsp5/3CLpro inhibitors K.Y. Chen, T. Krischuns, L.Ortega Varga, E. Harigua-Souiai, S. Paisant, A. Zettor, et al. (+11)
28 [GO] 2022―Mar―07 Establishment of a stable SARS-CoV-2 replicon system for application in high-throughput screening Tomohisa Tanaka, Akatsuki Saito, Tatsuya Suzuki, Yoichi Miyamoto, Kazuo Takayama, Toru Okamoto, Kohji Moriishi
29 [GO] 2022―Feb―28 ACE2-Fc fusion protein overcomes viral escape by potently neutralizing SARS-CoV-2 variants of concern Tsung-I Tsai, Jahan S. Khalili, Mark Gilchrist, Andrew B. Waight, Daniella Cohen, Shi Zhuo, et al. (+6)
30 [GO] 2022―Jan―29 5-Iodotubercidin inhibits SARS-CoV-2 RNA synthesis Jianyuan Zhao, Qian Liu, Dongrong Yi, Quanjie Li, SaiSai Guo, Ling Ma, et al. (+7)
31 [GO] 2022―Jan―24 Remdesivir, Molnupiravir and Nirmatrelvir remain active against SARS-CoV-2 Omicron and other variants of concern Laura Vangeel, Winston Chiu, Steven De Jonghe, Piet Maes, Bram Slechten, Joren Raymenants, et al. (+4)
32 [GO] 2022―Jan―21 The omicron (B.1.1.529) SARS-CoV-2 variant of concern does not readily infect Syrian hamsters Rana Abdelnabi, Caroline S. Foo, Xin Zhang, Viktor Lemmens, Piet Maes, Bram Slechten, et al. (+5)
33 [GO] 2022―Jan―13 Very low levels of remdesivir resistance in SARS-COV-2 genomes after 18 months of massive usage during the COVID19 pandemic: A GISAID exploratory analysis Daniele Focosi, Fabrizio Maggi, Scott McConnell, Arturo Casadevall
34 [GO] 2022―Jan―13 Subcutaneous remdesivir administration prevents interstitial pneumonia in rhesus macaques inoculated with SARS-CoV-2 Brandi N. Williamson, Lizzette Pérez-Pérez, Benjamin Schwarz, Friederike Feldmann, Myndi G. Holbrook, Manmeet Singh, et al. (+13)
35 [GO] 2021―Dec―29 S-adenosylmethionine-dependent methyltransferase inhibitor DZNep blocks transcription and translation of SARS-CoV-2 genome with a low tendency to select for drug-resistant viral variants Ram Kumar, Nitin Khandelwal, Yogesh Chander, Himanshu Nagori, Assim Verma, Aditya Barua, et al. (+6)
36 [GO] 2021―Dec―18 COVID-19, Influenza and RSV: Surveillance-informed prevention and treatment - Meeting report from an isirv-WHO virtual conference Jennifer L. McKimm-Breschkin, Alan J. Hay, Bin Cao, Rebecca J. Cox, Jake Dunning, Ann C. Moen, et al. (+3)
37 [GO] 2021―Nov―24 Hydroxychloroquine and azithromycin used alone or combined are not effective against SARS-CoV-2 ex vivo and in a hamster model Maxime Cochin, Franck Touret, Jean-Sélim Driouich, Gregory Moureau, Paul-Rémi Petit, Caroline Laprie, et al. (+3)
38 [GO] 2021―Nov―18 2-((1H-indol-3-yl)thio)-N-phenyl-acetamides: SARS-CoV-2 RNA-dependent RNA polymerase inhibitors Jianyuan Zhao, Guoning Zhang, Yongxin Zhang, Dongrong Yi, Quanjie Li, Ling Ma, et al. (+8)
39 [GO] 2021―Nov―10 Picomolar inhibition of SARS-CoV-2 variants of concern by an engineered ACE2-IgG4-Fc fusion protein Hristo L. Svilenov, Julia Sacherl, Alwin Reiter, Lisa S. Wolff, Cho-Chin Cheng, Marcel Stern, et al. (+10)
40 [GO] 2021―Nov―08 Development and characterization of SARS-CoV-2 variant-neutralizing monoclonal antibodies Hongyu Qiu, Xin-Yong Yuan, Teresa Cabral, Kathy Manguiat, Alyssia Robinson, Heidi Wood, et al. (+8)
41 [GO] 2021―Oct―21 Inhibition of endocytosis of porcine reproductive and respiratory syndrome virus by rottlerin and its potential prophylactic administration in piglets Yeong-Lim Kang, Changin Oh, So-Hyun Ahn, Jong-Chul Choi, Hwi-Yeon Choi, Sang-Won Lee, et al. (+4)
42 [GO] 2021―Oct―08 SARS-CoV-2 monoclonal antibodies with therapeutic potential: Broad neutralizing activity and No evidence of antibody-dependent enhancement Ying-Ting Wang, Robert D. Allen, Kenneth Kim, Norazizah Shafee, Andrew J. Gonzalez, Michael N. Nguyen, et al. (+9)
43 [GO] 2021―Oct―07 A fluorescence-based, gain-of-signal, live cell system to evaluate SARS-CoV-2 main protease inhibition Rama Dey-Rao, George R. Smith, Uddhav Timilsina, Zackary Falls, Ram Samudrala, Spyridon Stavrou, Thomas Melendy
44 [GO] 2021―Aug―24 Identification of Niemann-Pick C1 protein as a potential novel SARS-CoV-2 intracellular target Isabel García-Dorival, Miguel Ángel Cuesta-Geijo, Lucía Barrado-Gil, Inmaculada Galindo, Urtzi Garaigorta, Jesús Urquiza, et al. (+6)
45 [GO] 2021―Aug―09 Polyphenylene carboxymethylene (PPCM) microbicide repurposed as antiviral against SARS-CoV-2. Proof of concept in primary human undifferentiated epithelial cells Olivier Escaffre, Alexander N. Freiberg
46 [GO] 2021―Aug―08 A tetrameric ACE2 protein broadly neutralizes SARS-CoV-2 spike variants of concern with elevated potency Adam Leach, F. Tudor Ilca, Zulaikha Akbar, Mathieu Ferrari, Emma M. Bentley, Giada Mattiuzzo, et al. (+4)
47 [GO] 2021―Jul―23 Identification and evaluation of potential SARS-CoV-2 antiviral agents targeting mRNA cap guanine N7-Methyltransferase Renata Kasprzyk, Tomasz J. Spiewla, Miroslaw Smietanski, Sebastian Golojuch, Laura Vangeel, Steven De Jonghe, et al. (+4)
48 [GO] 2021―Jul―12 Preclinical evaluation of Imatinib does not support its use as an antiviral drug against SARS-CoV-2 Franck Touret, Jean-Sélim Driouich, Maxime Cochin, Paul Rémi Petit, Magali Gilles, Karine Barthélémy, et al. (+6)
49 [GO] 2021―Jul―08 A mouse model of lethal respiratory dysfunction for SARS-CoV-2 infection Esther S. Gan, Ayesa Syenina, Martin Linster, Benson Ng, Summer L. Zhang, Satoru Watanabe, et al. (+4)
50 [GO] 2021―Jun―26 A robust SARS-CoV-2 replication model in primary human epithelial cells at the air liquid interface to assess antiviral agents Thuc Nguyen Dan Do, Kim Donckers, Laura Vangeel, Arnab K. Chatterjee, Philippe A. Gallay, Michael D. Bobardt, et al. (+5)
51 [GO] 2021―Jun―19 Selinexor, a novel selective inhibitor of nuclear export, reduces SARS-CoV-2 infection and protects the respiratory system in vivo Trinayan Kashyap, Jackelyn Murray, Christopher J. Walker, Hua Chang, Sharon Tamir, Bing Hou, et al. (+4)
52 [GO] 2021―May―16 Virucidal and antiviral activity of astodrimer sodium against SARS-CoV-2 in vitro Jeremy R.A. Paull, Graham P. Heery, Michael D. Bobardt, Alex Castellarnau, Carolyn A. Luscombe, Jacinth K. Fairley, Philippe A. Gallay
53 [GO] 2021―Apr―21 A cell-based assay to discover inhibitors of SARS-CoV-2 RNA dependent RNA polymerase Jianyuan Zhao, SaiSai Guo, Dongrong Yi, Quanjie Li, Ling Ma, Yongxin Zhang, et al. (+7)
54 [GO] 2021―Apr―17 Discovery of Chebulagic Acid and Punicalagin as Novel Allosteric Inhibitors of SARS-CoV-2 3CLpro Ruikun Du, Laura Cooper, Zinuo Chen, Hyun Lee, Lijun Rong, Qinghua Cui
55 [GO] 2021―Mar―27 Proteomic Analysis Identifies the RNA Helicase DDX3X as a Host Target Against SARS-CoV-2 Infection Fabiola Ciccosanti, Martina Di Rienzo, Alessandra Romagnoli, Francesca Colavita, Giulia Refolo, Concetta Castilletti, et al. (+8)
56 [GO] 2021―Mar―11 Emetine suppresses SARS-CoV-2 replication by inhibiting interaction of viral mRNA with eIF4E Ram Kumar, Mohammad Afsar, Nitin Khandelwal, Yogesh Chander, Thachamvally Riyesh, Ramesh Kumar Dedar, et al. (+6)
57 [GO] 2021―Mar―11 Combined in silico and in vitro approaches identified the antipsychotic drug lurasidone and the antiviral drug elbasvir as SARS-CoV2 and HCoV-OC43 inhibitors Mario Milani, Manuela Donalisio, Rafaela Milan Bonotto, Edoardo Schneider, Irene Arduino, Francesco Boni, et al. (+3)
58 [GO] 2021―Feb―06 Genetic Conservation of SARS-CoV-2 RNA Replication Complex in Globally Circulating Isolates and Recently Emerged Variants from Humans and Minks Suggests Minimal Pre-Existing Resistance to Remdesivir Ross Martin, Jiani Li, Aiyippa Parvangada, Jason Perry, Tomas Cihlar, Hongmei Mo, et al. (+2)
59 [GO] 2021―Jan―27 Dual Inhibition of SARS-CoV-2 and Human Rhinovirus with Protease Inhibitors in Clinical Development Cheng Liu, Sandro Boland, Michael D. Scholle, Dorothee Bardiot, Arnaud Marchand, Patrick Chaltin, et al. (+7)
60 [GO] 2021―Jan―13 Inhibition of coronavirus infection by a synthetic STING agonist in primary human airway system Qingyuan Zhu, Yaling Zhang, Li Wang, Xiangyu Yao, Daitze Wu, Junjun Cheng, et al. (+4)
61 [GO] 2021―Jan―08 The rocaglate CR-31-B (-) inhibits SARS-CoV-2 replication at non-cytotoxic, low nanomolar concentrations in vitro and ex vivo Christin Müller, Wiebke Obermann, Nadja Karl, Hans-Guido Wendel, Gaspar Taroncher-Oldenburg, Stephan Pleschka, et al. (+3)
62 [GO] 2020―Dec―10 Antiviral activity against Middle East Respiratory Syndrome Coronavirus by Montelukast, an anti-asthma drug Hanjie Jonathan Gan, Amaravadhi Harikishore, Jihye Lee, Sangeun Jeon, Sreekanth Rajan, Ming Wei Chen, et al. (+3)
63 [GO] 2020―Nov―25 Ionophore antibiotic X-206 is a potent inhibitor of SARS-CoV-2 infection in vitro Esben B. Svenningsen, Jacob Thyrsted, Julia Blay-Cadanet, Han Liu, Shaoquan Lin, Jaime Moyano Villameriel, et al. (+5)
64 [GO] 2020―Nov―17 A bacterial artificial chromosome (BAC)-vectored noninfectious replicon of SARS-CoV-2 Yang Zhang, Wuhui Song, Shuiye Chen, Zhenghong Yuan, Zhigang Yi
65 [GO] 2020―Oct―19 Antiviral activity and safety of remdesivir against SARS-CoV-2 infection in human pluripotent stem cell-derived cardiomyocytes Seong Woo Choi, Jin Soo Shin, Soon-Jung Park, Eunhye Jung, Yun-Gwi Park, Jiho Lee, et al. (+7)
66 [GO] 2020―Sep―19 Cryptotanshinone Protects Porcine Alveolar Macrophages from Infection with Porcine Reproductive and Respiratory Syndrome Virus Chang Huang, Jiaqi Zhu, Ling Wang, Alexander Chu, Yexuan Yin, Kaneha Vali, et al. (+2)
67 [GO] 2020―Sep―07 Structural-based virtual screening and in vitro assays for small molecules inhibiting the feline coronavirus 3CL protease as a surrogate platform for coronaviruses Sirin Theerawatanasirikul, Chih Jung Kuo, Nanthawan Phecharat, Jullada Chootip, Chalermpol Lekcharoensuk, Porntippa Lekcharoensuk
68 [GO] 2020―Sep―06 Evaluation of SARS-CoV-2 3C-like protease inhibitors using self-assembled monolayer desorption ionization mass spectrometry Zachary A. Gurard-Levin, Cheng Liu, Andreas Jekle, Ruchika Jaisinghani, Suping Ren, Koen Vandyck, et al. (+9)
69 [GO] 2020―Jul―30 The chemokine receptor antagonist cenicriviroc inhibits the replication of SARS-CoV-2 in vitro Mika Okamoto, Masaaki Toyama, Masanori Baba
70 [GO] 2020―Jul―29 An enzyme-based immunodetection assay to quantify SARS-CoV-2 infection Carina Conzelmann, Andrea Gilg, Rüdiger Groß, Desiree Schütz, Nico Preising, Ludger Ständker, et al. (+7)
71 [GO] 2020―Jul―15 In vitro evaluation of antiviral activity of single and combined repurposable drugs against SARS-CoV-2 Andrés Pizzorno, Blandine Padey, Julia Dubois, Thomas Julien, Aurélien Traversier, Victoria Dulière, et al. (+4)
72 [GO] 2020―Jul―15 Lower prevalence of antibodies neutralizing SARS-CoV-2 in group O French blood donors Pierre Gallian, Boris Pastorino, Pascal Morel, Jacques Chiaroni, Laetitia Ninove, Xavier de Lamballerie
73 [GO] 2020―Jul―10 Concerns about pharmacokinetic (PK) and pharmacokinetic-pharmacodynamic (PK-PD) studies in the new therapeutic area of COVID-19 infection Nicolas Venisse, Gilles Peytavin, Stephane Bouchet, Marie-Claude Gagnieu, Rodolphe Garraffo, Romain Guilhaumou, Caroline Solas
74 [GO] 2020―Jul―10 Characterization of heparin and severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) spike glycoprotein binding interactions So Young Kim, Weihua Jin, Amika Sood, David W. Montgomery, Oliver C. Grant, Mark M. Fuster, et al. (+5)
75 [GO] 2020―Jul―10 Immunoglobulin fragment F(ab’)2 against RBD potently neutralizes SARS-CoV-2 in vitro Xiaoyan Pan, Pengfei Zhou, Tiejiong Fan, Yan Wu, Jing Zhang, Xiaoyue Shi, et al. (+9)
76 [GO] 2020―Jun―19 The influence of interferon-lambda on restricting Middle East Respiratory Syndrome Coronavirus replication in the respiratory epithelium Yung Jin Jeon, Chan Hee Gil, Ara Jo, Jina Won, Sujin Kim, Hyun Jik Kim
77 [GO] 2020―Jun―18 A Library of Nucleotide Analogues Terminate RNA Synthesis Catalyzed by Polymerases of Coronaviruses that Cause SARS and COVID-19 Steffen Jockusch, Chuanjuan Tao, Xiaoxu Li, Thomas K. Anderson, Minchen Chien, Shiv Kumar, et al. (+3)
78 [GO] 2020―May―13 Identification of SARS-CoV RBD-targeting monoclonal antibodies with cross-reactive or neutralizing activity against SARS-CoV-2 Wanbo Tai, Xiujuan Zhang, Yuxian He, Shibo Jiang, Lanying Du
79 [GO] 2020―Apr―29 Antiviral Activities of Type I Interferons to SARS-CoV-2 Infection Emily Mantlo, Natalya Bukreyeva, Junki Maruyama, Slobodan Paessler, Cheng Huang
80 [GO] 2020―Apr―21 Ivermectin and COVID-19: a report in Antiviral Research, widespread interest, an FDA warning, two letters to the editor and the authors' responses Mike Bray, Craig Rayner, François Noël, David Jans, Kylie Wagstaff
81 [GO] 2020―Apr―10 Remdesivir and SARS-CoV-2: Structural requirements at both nsp12 RdRp and nsp14 Exonuclease active-sites Ashleigh Shannon, Nhung Thi-Tuyet Le, Barbara Selisko, Cecilia Eydoux, Karine Alvarez, Jean-Claude Guillemot, et al. (+4)
82 [GO] 2020―Apr―07 Type 1 interferons as a potential treatment against COVID-19 Erwan Sallard, François-Xavier Lescure, Yazdan Yazdanpanah, France Mentre, Nathan Peiffer-Smadja
83 [GO] 2020―Apr―06 Coronavirus membrane fusion mechanism offers as a potential target for antiviral development Tiffany Tang, Miya Bidon, Javier A. Jaimes, Gary R. Whittaker, Susan Daniel
84 [GO] 2020―Apr―03 The FDA-approved Drug Ivermectin inhibits the replication of SARS-CoV-2 in vitro Leon Caly, Julian D. Druce, Mike G. Catton, David A. Jans, Kylie M. Wagstaff
85 [GO] 2020―Apr―03 Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro Ka-Tim Choy, Alvina Yin-Lam Wong, Prathanporn Kaewpreedee, Sin-Fun Sia, Dongdong Chen, Kenrie Pui Yan Hui, et al. (+6)
86 [GO] 2020―Mar―06 Of chloroquine and COVID-19 Franck Touret, Xavier de Lamballerie
87 [GO] 2020―Mar―01 A potential role for integrins in host cell entry by SARS-CoV-2 Christian JA Sigrist, Alan Bridge, Philippe Le Mercier
88 [GO] 2020―Feb―27 Efficacy of anti-influenza immunoglobulin (FLU-IGIV) in ferrets and mice infected with 2009 pandemic influenza virus Hongyu Qiu, Hanne Andersen, E. Bart Tarbet, F. Salih Muhammad, Trevor Carnelley, Russell Pronyk, et al. (+2)
89 [GO] 2020―Feb―10 The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade B. Coutard, C. Valle, X. de Lamballerie, B. Canard, N.G. Seidah, E. Decroly
 [1] 

89 Results       Page 1



[de][en]

Last change 2022―Feb―03 17:06:14 UTC

© Daten-Quadrat 2022       Done in 0.014 sec